The Dentist Exodus: 2026 Will Be Ugly for Associate Hiring

The Dentist Exodus: 2026 Will Be Ugly for Associate Hiring

Dentists are selling practices and retiring faster than they're starting new ones. The Journal of Dental Education reports a 15% increase in practice transitions since 2021. Translation: associates are becoming harder to find and hiring them costs more.

Why? Boomer dentists made money hand-over-fist from 1985-2010. They built equity. Now they're exiting. Gen-X dentists (15-25 years in) are buying practices at 8-9x EBITDA. Expensive. To justify the purchase, they cut associate salaries or limit growth.

New grads want $150K+ salary, clinical autonomy, and a path to ownership. Those demands are reasonable. But the practices paying it are already bought out. The ones selling are cutting associate budgets to boost sale price.

What happens: practices without associate talent can't grow production. They stall. Then they sell, repeating the cycle.

If you're planning to hire an associate in 2026, do it now or pay 10-15% more. If you're selling soon, remember: associate retention makes your practice worth more to a buyer than associate turnover. Build it now, sell the value later.

Why The Associate Market Is Broken

The associate hiring market has two fatal structural problems:

1. Boomer dentists are exiting en masse
Dentists aged 60-70 (the Boomer cohort) represent 35-40% of all practicing dentists. They're selling practices at 7-9x EBITDA and retiring. This creates 10,000+ practice transitions annually through 2030. Each transition removes an experienced owner-operator and replaces them with a younger buyer who needs associate help but can't afford to pay well (they just took on $1M-2M in acquisition debt).

2. New grads can't afford to buy practices
Dental school debt averages $350K-400K. Starting salary as an associate: $140K-160K. After taxes and loan payments, they're taking home $70K-80K. They can't save for a down payment on a $1.5M-2M practice purchase (requires $300K-400K down). So they stay associates longer, competing with each other for limited associate roles, which suppresses wages. But the practices that could pay them well (high-production, high-margin) are being bought by private equity or Gen-X dentists who cut associate comp to service acquisition debt.

Result: a vicious cycle where associates are underpaid, can't buy practices, and the practices that need them can't afford them because the owners are overleveraged.

The Math Of Practice Acquisition (And Why It Kills Associate Pay)

Let's model a typical practice acquisition to understand why associate salaries are getting squeezed.

Practice for sale:
Annual production: $1.8M
EBITDA: $540K (30%)
Sale price: 7.5x EBITDA = $4.05M

Buyer (Gen-X dentist, 15 years experience):
Down payment: $1M (25%, saved over 10 years)
Loan: $3.05M @ 7.5% interest, 10-year term
Annual debt service: $435K (principal + interest)

Post-acquisition financials:
EBITDA: $540K
Debt service: -$435K
Cash flow available for owner salary: $105K

The buyer just spent $1M down and took on $3M in debt to earn $105K annually. That's a terrible ROI. To fix it, they have two options:

Option A: Grow production 20% to increase EBITDA
New production: $2.16M
New EBITDA (same 30% margin): $648K
Cash flow after debt: $213K
This requires hiring an associate and increasing capacity.

Option B: Cut overhead 5 points to boost EBITDA without growth
Production: $1.8M (unchanged)
New EBITDA (35% margin): $630K
Cash flow after debt: $195K
This requires cutting staff, supplies, or associate pay.

most buyers choose Option B because it's faster and less risky. They cut associate salaries from $150K to $130K, reduce benefits, and eliminate ownership pathways. The associate leaves within 18 months. The buyer is back to square one, but now they've also damaged culture and patient retention.

Why Associate Retention Is Worth More Than You Think

Buyers undervalue associate retention during acquisition. They see the associate as a cost center ($150K salary) rather than a revenue driver ($400K-600K production). This is wrong.

Let's model the value of a high-performing associate who stays post-acquisition vs one who leaves:

Scenario A: Associate stays (retention)
Associate production: $500K annually
Associate salary: $150K (30% of production, competitive)
Net contribution to EBITDA: $500K × 35% margin = $175K
Associate tenure: 5+ years (stability, patient relationships, culture)
Practice sale value in 5 years: $1.8M + $500K associate production = $2.3M × 7x EBITDA @ 37% margin = $5.95M

Scenario B: Associate leaves year 2 (turnover)
Associate production year 1-2: $500K
Replacement process: 6 months vacant, 6 months ramp-up = 12 months lost production = $500K
Replacement associate (lower performer): $400K production, $140K salary
Net contribution: $400K × 32% margin = $128K
Practice sale value in 5 years: $1.8M + $400K = $2.2M × 6.5x EBITDA @ 32% margin = $4.55M

Difference: $1.4M in exit value from retaining the associate

The buyer who keeps the associate by paying $150K instead of cutting to $130K earns $1.4M more on exit. The $20K annual overpay ($100K over 5 years) returns 14x. This is obvious math, yet most buyers cut associate pay anyway because they're focused on short-term cash flow, not long-term enterprise value.

OPERATOR MATH

Let's model two strategies for a practice owner buying a $1.8M practice with an existing associate.

Strategy A: Cut associate pay to boost cash flow (short-term thinking)
Purchase price: $4.05M (7.5x EBITDA)
Down payment: $1M
Loan: $3.05M @ 7.5%, 10 years, $435K annual debt service
Year 1 EBITDA: $540K
Associate salary: Cut from $150K to $130K (save $20K)
Cash flow: $540K - $435K = $105K + $20K = $125K owner income
Year 2: Associate leaves (unhappy with pay cut), 6 months to replace, $250K lost production
Year 2 EBITDA: $450K (production down due to vacancy)
Cash flow: $450K - $435K = $15K owner income (ouch)
Year 3-5: Hire replacement at $140K, ramp to $400K production, EBITDA stabilizes at $520K
Average annual cash flow years 1-5: $98K
Exit value year 5: $2.2M × 6.5x = $4.55M (lower multiple due to associate turnover history)
Equity gain: $4.55M - $3.05M remaining loan = $1.5M
Total 5-year return: $1.5M equity + $490K cash flow = $1.99M

Strategy B: Retain associate with competitive pay + ownership path (long-term thinking)
Purchase price: $4.05M
Down payment: $1M
Loan: $3.05M @ 7.5%, 10 years, $435K annual debt service
Year 1 EBITDA: $540K
Associate salary: Maintain $150K + offer 5% equity vesting over 5 years
Cash flow: $540K - $435K = $105K owner income
Year 2-5: Associate stays, production grows to $550K, EBITDA improves to $600K (35% margin)
Average annual cash flow years 1-5: $135K
Exit value year 5: $2.3M × 7.5x = $5.95M (premium multiple for associate retention + growth)
Associate equity buyout: 5% × $5.95M = $298K (paid at exit)
Equity gain: $5.95M - $3.05M loan - $298K buyout = $2.6M
Total 5-year return: $2.6M equity + $675K cash flow = $3.275M

Delta: $1.285M over 5 years by retaining the associate

Strategy B costs $100K more in associate pay over 5 years ($20K/year) plus $298K equity buyout at exit. Total cost: $398K. Return: $1.285M. ROI: 3.2x.

THE TAKEAWAY

If you're buying a practice in 2026:

• Retain the associate at all costs. If the practice has a productive associate, keep them. Pay them well ($150K+), offer equity (5-10% vesting over 5 years), and invest in their development. Losing them will cost you $500K-1M in lost production and exit value.
• Model acquisition ROI with associate retention as a key variable. Don't just model EBITDA and debt service. Model what happens if the associate leaves vs stays. The difference is 7-figures on exit.
• If the practice doesn't have an associate, hire one immediately post-acquisition. You can't grow production solo. You need leverage. Hire an associate within 90 days, pay them $150K-160K, and give them a clear path to ownership. This is your growth engine.

If you're an associate in 2026:

• Demand $150K+ salary and an ownership pathway. You have leverage. There aren't enough associates to meet demand. If a practice won't pay competitively or offer equity, walk. Another practice will.
• Avoid practices with overleveraged buyers. If the owner just bought the practice at 8-9x EBITDA and is paying $400K+/year in debt service, they can't afford to pay you well or offer ownership. Find a stable practice with an owner who's been there 5+ years and is planning succession.
• Negotiate equity upfront. Don't accept promises of "maybe ownership later." Get it in writing: 5-10% equity vesting over 3-5 years, with a buyout formula at fair market value. This protects you and aligns incentives.

If you're a practice owner hiring an associate:

• Pay $150K-160K minimum, or 30-35% of production. Anything less and you'll lose them to a DSO or competitor in 12-18 months. The replacement cost is $100K-150K. Overpaying by $10K-20K annually is cheaper than turnover.
• Offer a clear ownership pathway. 5-10% equity vesting over 5 years, with option to buy the full practice at retirement. This is the only retention strategy that works long-term for high-performing associates.
• Invest in their development. Continuing ed stipends ($5K-10K/year), mentorship, autonomy. Associates stay where they grow. If you treat them like production machines, they leave.

The associate market is broken and getting worse. Practices that retain associates via competitive pay and ownership pathways will dominate 2026-2030. The ones that cut costs and churn associates will stagnate and sell at discounts. The gap is $1M+ in enterprise value. Choose wisely.